Digital therapeutics, when created empathetically to patients and health care professionals (HCPs), can show significant value to all stakeholders in the healthcare pathway [1]. A question at a recent NHS conference prompted an important question: if pharma is funding these innovations with a commercial motivation, how do you ensure equality in access to digital therapeutics?…
Read detailsThe key differentiator between ‘digital health and wellbeing technologies’ and ‘digital therapeutics’ is that the latter must show improved outcomes. Approximately 140 studies were published in 2017 which contained clinical evidence of digital health efficacy [1]. Clinically validated technologies have looked to show value for health systems by reducing emergency hospitalisation, A&E, ambulatory, drug and…
Read detailsDigital therapeutics do not yet have a widely agreed definition, though the market for them is expected to reach $9 billion by 2025. Their rise coincides with the intensification of the digital health market as a whole in recent years, which includes the widespread use of health and wellbeing technologies including fitness, sleep and diet…
Read detailspH Associates is a strategic Real World Evidence (RWE) consultancy that works collaboratively with industry, the NHS and academia to create projects that drive improvement in healthcare delivery. OPEN Health sit down with Sam Oliver, Joint Managing Director at pH associates to answer the following questions: What is Real World Evidence? How do we work with…
Read detailspH Associates is delighted to welcome Abi, Toby, Nancy and Jen to the pH family! Abi Mawer joins pH as an Associate Real-World Evidence Consultant. Abi has 5 years consulting experience and has worked in Harvey Walsh and The EarthWorks within the OPEN Health group. Abi has a BSc in Biomedical Sciences and an MSc…
Read detailspH Associates were delighted to meet with current and former clients at the NICE Conference #NICEConf18 last week and to have the opportunity to attend some thought-provoking breakout sessions. Of particular interest was a topical session focused on ‘Tackling Antimicrobial Resistance Globally and Locally’, with Nick Crabb (Programme Director, Scientific Affairs, NICE), Susan Hopkins (Chair…
Read detailsAmanda Pulfer, MD, pH Associates Dorinda Hickey, CEO, OPEN Access Consulting On Tuesday 26th May The National Institute for Health and Care Excellence (NICE) will host their conference at the Hilton Deansgate Hotel Manchester. The conference will bring together representatives from health, social care and industry to discuss the big challenges facing the health and care…
Read detailsJust yesterday, the US Food and Drug Administration (FDA) officially acknowledged a deeper appreciation for the expertise that patients and caregivers can bring to the drug development process.
Read detailsDespite being one of the largest and most rapidly growing sectors in the world, the healthcare industry has generally stuck stringently to a reactive, treatment-focused model. However, with many services close to breaking point, and power shifting rapidly towards technology and the patient themselves, there is heightening pressure on the industry to capitalise on other…
Read detailsWe are excited to present our poster at the 23rd Annual International Society for Pharmacoeconomics and Outcomes Research Meeting #ISPORBaltimore today. The results being presented are from an exploratory survey suggesting that industry professionals recognise Real World Evidence (RWE) as important in supporting brand value messages and report a direct positive impact of RWE on…
Read detailspH Associates welcomes Jacqui and Ewelina to the Patient Centred Outcomes (PCO) team and Bethany to the Data Management team. Jacqui Bernarde has joined pH Associates is a Research Assistant in the PCO team. Jacqui supports the running of PCO research projects, by conducting literature reviews, contributing to the design, collecting data, analysis and reporting…
Read detailsDo you need resource use data to provide supporting evidence that demonstrates the value of your brand? Despite offering clear benefits in terms of satisfying unmet clinical need, many new interventions face barriers to adoption within healthcare settings due to resourcing challenges beyond acquisition cost. pH Associates specialise in the design and implementation of non-interventional…
Read details
